bpc 157 fda warning december 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of bpc-157 fda warning 2025 september

J Am Coll Surg

10.1017/S0033583522000026 CrossRef Google Scholar View reference in article Keywords protein transduction domain, cell-penetrating peptide, PTD, CPP, TCTP-PTD, nose-to-brain delivery, nasal delivery, antidiabetic peptides Citation Maeng J and Lee K (2022) Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides

Muscle injury recovery pathway research

doi: 10.1177/03635465211028547

In biochemical systems, actin-binding peptides derived from thymosin beta-4 function as regulators of cytoskeletal assembly by influencing the equilibrium between monomeric and filamentous actin

Several approaches are being investigated to overcome this limitation